2002
DOI: 10.1046/j.1440-1827.2002.01328.x
|View full text |Cite
|
Sign up to set email alerts
|

Hepatoid adenocarcinoma in Barrett’s esophagus associated with achalasia: First case report

Abstract: We report an unusual hepatoid adenocarcinoma in Barrett's esophagus with achalasia, which developed in a 44-year-old Japanese woman. The patient received an esophago-gastrectomy after diagnosis of the tumor and achalasia at the lower esophagus, 4 months before her death due to multiple metastatic tumors of the liver. The main granular tumor removed surgically was a hepatoid adenocarcinoma, mainly composed of clear cancer cells (alpha-1 antitrypsin, albumin and alpha-fetoprotein positive), with elements of chor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
19
0

Year Published

2006
2006
2018
2018

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(21 citation statements)
references
References 20 publications
(33 reference statements)
2
19
0
Order By: Relevance
“…Of particular interest, 2 patients (9.1%) complained of clinical symptoms referable to a concomitant pancreatic neuroendocrine tumor (1 insulinoma and 1 glucagonoma, respectively), underlining the possible association of pancreatic HC with other pancreatic neoplasms. Elevated AFP serum levels might be present at time of diagnosis in all HCs, despite tumor primary site [7,8,11,12,28,29,30,31,32,33,34]. Our review of pancreatic forms indeed reports a rate of 54.5% (12 out of 22 cases), bearing in mind that 3 papers did not report or did not assess AFP levels of their cases.…”
Section: Discussion and Review Of The Literaturementioning
confidence: 72%
See 1 more Smart Citation
“…Of particular interest, 2 patients (9.1%) complained of clinical symptoms referable to a concomitant pancreatic neuroendocrine tumor (1 insulinoma and 1 glucagonoma, respectively), underlining the possible association of pancreatic HC with other pancreatic neoplasms. Elevated AFP serum levels might be present at time of diagnosis in all HCs, despite tumor primary site [7,8,11,12,28,29,30,31,32,33,34]. Our review of pancreatic forms indeed reports a rate of 54.5% (12 out of 22 cases), bearing in mind that 3 papers did not report or did not assess AFP levels of their cases.…”
Section: Discussion and Review Of The Literaturementioning
confidence: 72%
“…The first case was reported by Ishikura et al [4] and concerned HC in the stomach. Since then, its occurrence has been described in gonadal yolk sac as well as in several non-germ cell origin primary sites, including esophagus, ampulla of Vater, colon, lung, gallbladder, adrenal gland, kidney, urinary bladder, ovary, uterus, vagina, and testicle [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]. Microscopic ‘stigmata' of those origins are typically detectable in tumor focal areas.…”
Section: Introductionmentioning
confidence: 99%
“…To date, eight cases exhibiting AFP-producing carcinomas of the EGJ have been reported in the literature (Table 1) [13][14][15][16][17][18][19][20]. Five cases were reported from Asia and three were reported from other regions.…”
Section: Discussionmentioning
confidence: 99%
“…Five cases were reported from Asia and three were reported from other regions. An association with Barrett's esophagus was reported in half of the cases [13,14,16,20], but in others no relationship was found [15,[17][18][19]. The histological subtypes were as follows: adenocarcinoma (n = 3) [16,17,19], hepatoid adenocarcinoma (n = 3) [14,15,18], adenocarcinoma/hepatoid adenocarcinoma (n = 1) [20], and mixed-type (n = 1) [13].…”
Section: Discussionmentioning
confidence: 99%
“…Alfa-fetoprotein (AFP)-producing gastrointestinal carcinomas have been mostly reported as arising in the stomach [1][2][3]; there were few cases reported with esophageal cancers [4][5][6][7][8][9][10][11][12][13][14]. Adenocarcinoma with enteroblastic differentiation is a subtype of AFP-producing adenocarcinoma.…”
Section: Introductionmentioning
confidence: 99%